Index by author
May 1, 2024; Volume 65,Issue 5
Calais, Jeremie
- You have access[68Ga]Ga-FAPI-46 PET in a Borderline Ovarian TumorLena M. Unterrainer, Sanaz Memarzadeh, Neda A. Moatamed, Matthias R. Benz, Johannes Czernin and Jeremie CalaisJournal of Nuclear Medicine May 1, 2024, 65 (5) 820-821; DOI: https://doi.org/10.2967/jnumed.123.266732
- You have accessPSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?Lena M. Unterrainer, Kathleen Ruchalski, Martin S. Allen-Auerbach, Jeremie Calais and Matthias R. BenzJournal of Nuclear Medicine May 1, 2024, 65 (5) 818-819; DOI: https://doi.org/10.2967/jnumed.123.266722
Calvo Martinez, Lourdes
- You have accessOptimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain TrialGeraldine Gebhart, Marleen Keyaerts, Thomas Guiot, Patrick Flamen, Manuel Ruiz-Borrego, Agostina Stradella, Begoña Bermejo, Santiago Escriva-de-Romani, Lourdes Calvo Martínez, Nuria Ribelles, María Fernandez-Abad, Cinta Albacar, Marco Colleoni, Laia Garrigos, Manuel Atienza de Frutos, Florence Dalenc, Aleix Prat, Frederik Marmé, Peter Schmid, Khaldoun Kerrou, Sofia Braga, Petra Gener, Miguel Sampayo-Cordero, Javier Cortés, José Manuel Pérez-García and Antonio Llombart-CussacJournal of Nuclear Medicine May 1, 2024, 65 (5) 708-713; DOI: https://doi.org/10.2967/jnumed.123.266384
Canis, Martin
- You have accessImpact of 18F-FDG PET Intensity Normalization on Radiomic Features of Oropharyngeal Squamous Cell Carcinomas and Machine Learning–Generated BiomarkersStefan P. Haider, Tal Zeevi, Kariem Sharaf, Moritz Gross, Amit Mahajan, Benjamin H. Kann, Benjamin L. Judson, Manju L. Prasad, Barbara Burtness, Mariam Aboian, Martin Canis, Christoph A. Reichel, Philipp Baumeister and Seyedmehdi PayabvashJournal of Nuclear Medicine May 1, 2024, 65 (5) 803-809; DOI: https://doi.org/10.2967/jnumed.123.266637
Capanu, Marinela
- You have access18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L. Cytryn, Neeta Pandit-Taskar, Melissa A. Lumish, Steven B. Maron, Ping Gu, Geoffrey Y. Ku, Joanne F. Chou, Marinela Capanu, Ariel Antoine, Diane Loegel, Lara Feder, Steven Philemond, Serge K. Lyashchenko, Jason S. Lewis, Viktoriya Paroder, Amitabh Srivastava, Laura H. Tang, Heiko Schoder and Yelena Y. JanjigianJournal of Nuclear Medicine May 1, 2024, 65 (5) 722-727; DOI: https://doi.org/10.2967/jnumed.123.267186
Carter, Lukas M.
- You have accessMIRD Pamphlet No. 29: MIRDy90—A 90Y Research Microsphere Dosimetry ToolHarry Marquis, Juan C. Ocampo Ramos, Lukas M. Carter, Pat Zanzonico, Wesley E. Bolch, Richard Laforest and Adam L. KesnerJournal of Nuclear Medicine May 1, 2024, 65 (5) 794-802; DOI: https://doi.org/10.2967/jnumed.123.266743
Cherry, Simon R.
- You have accessHigh-Temporal-Resolution Kinetic Modeling of Lung Tumors with Dual-Blood Input Function Using Total-Body Dynamic PETYiran Wang, Yasser G. Abdelhafez, Benjamin A. Spencer, Rashmi Verma, Mamta Parikh, Nicholas Stollenwerk, Lorenzo Nardo, Terry Jones, Ramsey D. Badawi, Simon R. Cherry and Guobao WangJournal of Nuclear Medicine May 1, 2024, 65 (5) 714-721; DOI: https://doi.org/10.2967/jnumed.123.267036
Choi, Jimi
- You have accessCancer Risk in Graves Disease with Radioactive 131I Treatment: A Nationwide Cohort StudyKyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik and Sin Gon KimJournal of Nuclear Medicine May 1, 2024, 65 (5) 693-699; DOI: https://doi.org/10.2967/jnumed.123.266531
Choi, Kyung Mook
- You have accessCancer Risk in Graves Disease with Radioactive 131I Treatment: A Nationwide Cohort StudyKyeong Jin Kim, Jimi Choi, Kyoung Jin Kim, Eyun Song, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik and Sin Gon KimJournal of Nuclear Medicine May 1, 2024, 65 (5) 693-699; DOI: https://doi.org/10.2967/jnumed.123.266531
Chou, Joanne F.
- You have access18F-BMS-986229 PET to Assess Programmed-Death Ligand 1 Status in Gastroesophageal CancerSamuel L. Cytryn, Neeta Pandit-Taskar, Melissa A. Lumish, Steven B. Maron, Ping Gu, Geoffrey Y. Ku, Joanne F. Chou, Marinela Capanu, Ariel Antoine, Diane Loegel, Lara Feder, Steven Philemond, Serge K. Lyashchenko, Jason S. Lewis, Viktoriya Paroder, Amitabh Srivastava, Laura H. Tang, Heiko Schoder and Yelena Y. JanjigianJournal of Nuclear Medicine May 1, 2024, 65 (5) 722-727; DOI: https://doi.org/10.2967/jnumed.123.267186
Colleoni, Marco
- You have accessOptimal [18F]FDG PET/CT Cutoff for Pathologic Complete Response in HER2-Positive Early Breast Cancer Patients Treated with Neoadjuvant Trastuzumab and Pertuzumab in the PHERGain TrialGeraldine Gebhart, Marleen Keyaerts, Thomas Guiot, Patrick Flamen, Manuel Ruiz-Borrego, Agostina Stradella, Begoña Bermejo, Santiago Escriva-de-Romani, Lourdes Calvo Martínez, Nuria Ribelles, María Fernandez-Abad, Cinta Albacar, Marco Colleoni, Laia Garrigos, Manuel Atienza de Frutos, Florence Dalenc, Aleix Prat, Frederik Marmé, Peter Schmid, Khaldoun Kerrou, Sofia Braga, Petra Gener, Miguel Sampayo-Cordero, Javier Cortés, José Manuel Pérez-García and Antonio Llombart-CussacJournal of Nuclear Medicine May 1, 2024, 65 (5) 708-713; DOI: https://doi.org/10.2967/jnumed.123.266384